Thomas M. Tully
Chairman & CEO, Intact Medical, NMT Medical, Organogenesis, Pfizer Hospital Products, Johnson & Johnson

Thomas M. Tully - Carefree, AZ - is currently Chairman & CEO of IDev Technologies, Inc., a Houston based medical device company spun out of MD Anderson Cancer Center for the purpose of developing and commercializing minimally invasive devices for the treatment of peripheral vascular disease. Prior to that Mr. Tully served as President and Chief Executive Officer of Neothermia Corporation, a medical device company specializing in novel minimally invasive tissue biopsy systems, from August 2000 to April 2005. Prior to joining Neothermia, he served as President and CEO of NMT Medical, a Nasdaq company focused on the development and marketing of innovative, minimally invasive medical devices for cardiology, radiology and neurosurgery. Additionally, Mr. Tully has served as President of the Institute of Molecular Biology, Inc., a biotechnology company focused on tissue repair and regeneration, and as President of Organogenesis, Inc., a biotechnology company focused on the commercialization of medical device applications of tissue engineering. Earlier in his career, Mr. Tully served for three years as the President of the Schneider division of Pfizer, Inc. and spent nine years in various executive positions in consumer products and medical devices at Johnson & Johnson including the founding President of Johnson & Johnson Interventional Systems. Mr. Tully currently serves as a director of Arbios Systems, a development stage medical device company developing technologies for external support of patients in acute and chronic liver failure and as a director of Tyrx Medical, a private company developing novel materials based medical devices.


BACK